An interventional study of group education and conventional smoking cessation management in Smoking Cessation and Hypertension, sponsored by Shanghai Jiao Tong University School of Medicine. Not yet recruiting. Open to male participants aged 65 Years to 84 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-03.
Sponsored by Shanghai Jiao Tong University School of Medicine · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Smoking elderly males with stage 1 and 2 hypertension who currently smoked at least one cigarette per day and were willing to quit smoke will be invited to this cluster randomized, controlled, interventional, open clinical trial. The investigators will provide participants with group education of smoking cessation and their blood pressure measured at clinic at the sixth month is the primary endpoint. The investigators aim to explore how group education of smoking cessation effects smoking cessation, hypertension control and cardiovascular events.
1,583 studies on the registry are indexed under Smoking Cessation; 196 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 163 across 1,425 interventional studies indexed under Smoking Cessation.
Browse Smoking Cessation studies →Shanghai Jiao Tong University School of Medicine is the lead sponsor of 374 studies on the registry; 110 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The investigators will provide experimental groups with group education of smoking cessation, including lectures in groups of 50 to 100 people and panel discussion in groups of 5 to 10 people.
Behavioral: group education
The investigators will provide control groups with conventional smoking cessation management, including regular follow-up of smoking status and giving advice of smoking cessation.
Behavioral: conventional smoking cessation management
Group education is one of strategies and behavioural interventions of smoking cessation. Lectures, group meeting for mutual support, discussion of coping skills and suggestions for prevention relapse can help smokers quit smoking by providing support and encouragement from people in same condition.
Including regular follow-up of smoking status and giving advice of smoking cessation
change of clinic systolic blood pressure from baseline at the sixth month
Time frame: 6 months
Cardiovascular events (cardiovascular death, stroke,myocardial infarction)
Time frame: 6 months, 1 year, 2years, 3 years
change of clinical blood pressure and home blood pressure from baseline
Time frame: 1 month, 2 month, 3 month, 6 month, 1 year, 2 years, 3 years
Hypertension control rate
Time frame: 1 month, 2 month, 3 month, 6 month, 1 year, 2 years, 3 years
Biochemical smoking cessation rate
CO≤6 ppm
Time frame: 6 months
Self-reported 7-days smoking cessation rate
Time frame: 1 month, 2 month, 3 month, 6 month, 1 year, 2 years, 3 years
Self-reported long-term smoking cessation rate
Participants hadn't smoked for at least one month.
Time frame: 1 month, 2 month, 3 month, 6 month, 1 year, 2 years, 3 years
Self-reported average number of cigarettes smoked per day
Time frame: 1 month, 2 month, 3 month, 6 month, 1 year, 2 years, 3 years
Relapse rate
Time frame: 6 month
Mini-Mental State Examination score
The cognitive function of participants will be assessed by MMSE. The score of MMSE ranges from 0 (worse) to 30 (better).
Time frame: 6 months
FEV1-Pulmonary functions
Forced expiratory volume in 1 second (FEV1) is the volume of air exhaled in the first second during forced exhalation after maximum inspiration.
Time frame: 6 months
PEF-Pulmonary functions
Peak expiratory flow (PEF), the maximal flow that can be exhaled when blowing out at a steady rate.
Time frame: 6 months
FVC-Pulmonary functions
Forced vital capacity (FVC), is the maximum amount of air that can be exhaled when blowing out as fast as possible.
Time frame: 6 months
Fagerstrom Test for Nicotine Dependence score
The score of FTND ranges from 0 to 10. Participants with higher scores have higher degree of tobacco dependence and are less likely to maintain the status of smoking cessation.
Time frame: 6 months
Carbon monoxide concentration breathed
Time frame: 6 months
Adverse events, including nicotine withdrawal symptoms and other adverse events.
Nicotine withdrawal symptoms were quantified using the Minnesota Tobacco Withdrawal Scale (MNWS).
Time frame: 1 month, 2 month, 3 month, 6 month, 1 year, 2 years, 3 years
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Oct 2022; primary completion for Jan 2027, 50 months later.
Of 547 non-industry interventional studies with no phase under Smoking Cessation, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 50 months is above that.
Counting every sponsor, half of 564 studies reached it within 24 months; a quarter within 12 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Jiao Tong University School of Medicine →